$20,000,000 at the end of each fiscal quarter and limitations on liens, indebtedness, fundamental changes and dispositions, changes in the nature of the business of Parent and its subsidiaries, loans, advances and investments, sale and leaseback transactions, capital expenditures, restricted payments, use of proceeds in violation of Federal Reserve regulations and anti-corruption, anti-terrorism and anti-money laundering regulations, transactions with affiliates, limitations on dividends and other payment restrictions affecting subsidiaries, limitations on negative pledges, modifications of indebtedness, organizational documents and certain other agreements, violations of the Investment Company Act of 1940, as amended, violations of ERISA and environmental regulations, and plans of division. The Credit Agreement also contains usual and customary events of default, including: non-payment of principal, interest, fees and other amounts; material breach of a representation or warranty; default on other material debt; bankruptcy or insolvency; incurrence of certain material ERISA liabilities; material judgments; impairment of loan documentation; violation of subordination provisions; and change of control.
| 6. | Notes Acquired or Converted. |
Any Notes repurchased by us pursuant to the Fundamental Change Repurchase Right or converted by Holders pursuant to the Make-Whole Conversion Right will be cancelled by the Trustee, pursuant to the terms of the Indenture.
| 7. | Plans or Proposals of the Issuer. |
On August 5, 2019, the Issuer entered into the Merger Agreement, pursuant to which Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and an indirect wholly owned subsidiary of Parent. At the effective time of the Merger, each share of Issuer common stock was converted into the right to receive the Merger Consideration.
On November 19, 2019, in connection with the completion of the Merger, the Issuer notified the NYSE that trading in its shares of common stock should be suspended and the listing of such shares on the NYSE should be removed. In addition, the Issuer requested that the NYSE file with the SEC an application on Form 25 to delist and deregister the shares of the Issuer’s common stock under Section 12(b) of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”). On November 19, 2019, the NYSE informed the Issuer that it had filed the Form 25 with the SEC. On or about November 29, 2019, the Issuer intends to file with the SEC a Form 15 requesting that its reporting obligations under Section 13(a) and 15(d) of the Exchange Act be suspended.
As disclosed by the Issuer in its Current Report on Form 8-K filed on November 20, 2019, in connection with the completion of the Merger, certain of the former executive officers and members of the Issuer’s board of directors were replaced with the individuals listed on Annex A to this Notice.
Except as noted in this Notice and in the documents incorporated by reference herein, the Issuer currently has no plans, proposals or negotiations that relate to or would result in any of the events described in Item 1006(c) of Regulation M-A issued under the Exchange Act.
| 8. | Interests of the Issuer and Directors, Executive Officers and Affiliates of the Issuer in the Notes. |
None of the Issuer, its associates or its majority-owned subsidiaries has any beneficial ownership interest in any of the Notes and during the 60 days preceding the date of this Notice, none of such persons has engaged in any transactions in the Notes. Based on a reasonable inquiry by the Issuer:
none of the Issuer or its executive officers, directors, subsidiaries or other affiliates has any beneficial interest in the Notes;
the Issuer will not purchase any Notes from such persons; and
during the 60 days preceding the date of this Notice, none of such officers, directors or affiliates has engaged in any transactions in the Notes.
A list of the directors and executive officers of the Issuer is attached to this Notice as Annex A.
| 9. | Agreements Involving the Notes. |
Except as described in this Notice, none of the Issuer, or to its knowledge, any of its affiliates, directors or executive officers, is a party to any contract, arrangement, understanding or agreement with any other person relating, directly or indirectly, to the Fundamental Change Repurchase Right or with respect to any of the Notes,